125 related articles for article (PubMed ID: 16299686)
1. Anti-renin-angiotensin-system drugs and development of anemia in chronic kidney disease.
Piccoli A; Pastori G; Pierobon E; Torraca S; Andreucci M; Sabbatini M; Cianciaruso B
J Nephrol; 2005; 18(5):585-91. PubMed ID: 16299686
[TBL] [Abstract][Full Text] [Related]
2. Pulse pressure and inhibition of renin-angiotensin system in chronic kidney disease.
Banerjee D; Brincat S; Gregson H; Contreras G; Streather C; Oliveira D; Nelson S
Nephrol Dial Transplant; 2006 Apr; 21(4):975-8. PubMed ID: 16384830
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy.
Artz MA; Hilbrands LB; Borm G; Assmann KJ; Wetzels JF
Nephrol Dial Transplant; 2004 Nov; 19(11):2852-7. PubMed ID: 15466882
[TBL] [Abstract][Full Text] [Related]
4. Untoward effects of chronic dual renin-angiotensin system blockade: influence of previous chronic renal failure.
Robles NR; Cancho B; Barroso S; Martín MV; Sánchez Casado E
Int J Clin Pract; 2006 Sep; 60(9):1035-9. PubMed ID: 16939543
[TBL] [Abstract][Full Text] [Related]
5. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
6. [Incidence and management of anemia in renal transplantation: an observational-French study].
Choukroun G; Deray G; Glotz D; Lebranchu Y; Dussol B; Bourbigot B; Lefrançois N; Cassuto-Viguier E; Toupance O; Hacen C; Lang P; Mazouz H; Martinez F
Nephrol Ther; 2008 Dec; 4(7):575-83. PubMed ID: 18672417
[TBL] [Abstract][Full Text] [Related]
7. Effects of the Renin-Angiotensin system blockade on hemoglobin levels in type 2 diabetic patients with chronic kidney disease.
Inoue A; Babazono T; Iwamoto Y
Am J Hypertens; 2008 Mar; 21(3):317-22. PubMed ID: 18202667
[TBL] [Abstract][Full Text] [Related]
8. Treatment of anemia in renal transplantation: impact of a stricter application of hemoglobin targets.
Gentil MA; Pérez-Valdivia MA; González-Roncero FM; López-Mendoza M; Cabello V; Bernal G; Suñer M; Pereira P
Transplant Proc; 2008 Nov; 40(9):2916-8. PubMed ID: 19010146
[TBL] [Abstract][Full Text] [Related]
9. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
[TBL] [Abstract][Full Text] [Related]
10. A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study.
Portolés J; López-Gómez JM; Aljama P
Nephrol Dial Transplant; 2007 Feb; 22(2):500-7. PubMed ID: 17023492
[TBL] [Abstract][Full Text] [Related]
11. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
Onuigbo MA
Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
Qureshi IZ; Abid K; Ambreen F; Qureshi AL
Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
[TBL] [Abstract][Full Text] [Related]
13. Risk factors of vascular access failure in patients on hemodialysis.
Gheith OA; Kamal MM
Iran J Kidney Dis; 2008 Oct; 2(4):201-7. PubMed ID: 19377238
[TBL] [Abstract][Full Text] [Related]
14. Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study.
Ritz E; Laville M; Bilous RW; O'Donoghue D; Scherhag A; Burger U; de Alvaro F;
Am J Kidney Dis; 2007 Feb; 49(2):194-207. PubMed ID: 17261422
[TBL] [Abstract][Full Text] [Related]
15. An oral adsorbent, AST-120, combined with a low-protein diet and RAS blocker, for chronic kidney disease.
Yorioka N; Kiribayashi K; Naito T; Ogata S; Yokoyama Y; Kyuden Y; Ogawa T; Wada K; Hayashi K; Hirabayashi A
J Nephrol; 2008; 21(2):213-20. PubMed ID: 18446716
[TBL] [Abstract][Full Text] [Related]
16. Late onset renal failure from angiotensin blockade (LORFFAB): a prospective thirty-month Mayo Health System clinic experience.
Onuigbo MA; Onuigbo NT
Med Sci Monit; 2005 Oct; 11(10):CR462-9. PubMed ID: 16192897
[TBL] [Abstract][Full Text] [Related]
17. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
[TBL] [Abstract][Full Text] [Related]
18. Erythropoiesis-stimulating protein therapy and the decline of renal function: a retrospective analysis of patients with chronic kidney disease.
Dean BB; Dylan M; Gano A; Knight K; Ofman JJ; Levine BS
Curr Med Res Opin; 2005 Jul; 21(7):981-7. PubMed ID: 16004664
[TBL] [Abstract][Full Text] [Related]
19. Haemoglobin level and vascular access survival in haemodialysis patients.
Garrancho JM; Kirchgessner J; Arranz M; Klinkner G; Rentero R; Ayala JA; Marcelli D
Nephrol Dial Transplant; 2005 Nov; 20(11):2453-7. PubMed ID: 16077146
[TBL] [Abstract][Full Text] [Related]
20. [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].
Renke M; Rutkowski P; Tylicki L; Zietkiewicz M; Larczyński W; Rutkowski B
Przegl Lek; 2008; 65(6):312-4. PubMed ID: 18853664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
